the present invention regards in particular an implanting device in the human or animal body , in which at least one part of the surface of said device is coated with a hyaluronic acid compound with a glycopeptide antibiotic . the idea is to bond a layer of hyaluronic acid to the surfaces of interest ( through the methods known in the art ), then incubate such surfaces with a solution of vancomycin in presence of condensing agents , in particular n - hydroxysuccinimide ( nhs ) and 1 - ethyl - 3 -( 3 - dimethylaminopropyl ) carbodiimide ( edc ), present simultaneously : an “ opaque ” layer , indicating the interaction between the previously bonded hyaluronic acid and vancomycin is formed on the surface after a few hours . this opaque layer is not formed in the absence of hyaluronic acid bonded to the surface , functionalised or non - functionalised , and it is not formed in absence of nhs / edc . from now henceforth , reference shall be made to “ hyaluronic acid complexes with vancomycin ”, where the term “ complex ” comprises any type of chemical / physical or simply physical interaction between hyaluronic acid and vancomycin , including hydrogen bond interactions , and / or van der waals interactions and / or electrostatic interactions etc , which is obtained through the precipitation of vancomycin or co - precipitation of hyaluronic acid and vancomycin in presence of cross - linking or condensing agents and in particular conditions ( ph and concentration of the solutions ). in an embodiment , the entire surface of the implanting device is coated with said hyaluronic acid / glycopeptide antibiotic complex bonded to the surface having a . alternatively , part of the device is coated with hyaluronic acid , and the formation of the complexes with vancomycin only occurs in this area . the implanting device according to the invention can be made of metal ( for example , steel , titanium or alloys thereof with other metals ) or made of plastic material ( such as for example polystyrene ) compatible for applications on the human or animal body , or made of ceramic material , both in form of the device and granulate / powder . in an embodiment , the device consists of a dental implant screw , preferably made of titanium or alloys thereof , possibly of the transmucosal type , or a screw , preferably made of titanium or alloys thereof , for spinal or skeletal fixation , or for fracture fixation , or an intervertebral disc , preferably made of titanium , alloys thereof or cobalt - chromium alloys or made of metal alloys commonly used for these applications . the surface of the device made of titanium can be smooth ( commonly referred to as “ machined ”) or preferably roughened according to methods known in the art , in particular through sand blasting , using alumina , titanium oxides or other sand blasting agents , roughening treatment using acids , or electrochemical roughening treatment . in an embodiment , the process of immobilizing the hyaluronic acid complex with the glycopeptide antibiotic on an implantable device according to the invention provides for the introduction of functional amino groups on the surface of the device . hyaluronic acid is bonded covalently to the surface amino groups , through the methods known in the art , and exerts the vancomycin “ capturing ” action thereof with formation of the complexes in presence of edc and nhs in the next step . the average molecular weight of hyaluronic acid may be comprised between 4 . 000 and 4 million da , preferably between 400 , 000 and 1 million da . the bond of hyaluronic acid to the amined surface may occur through the methods known in the art , for example by using edc / nhs , or by treating hyaluronic acid with periodate acid and subsequent reductive amination , or as described in wo2006 / 038056 a1 . the layer thus obtained may have a thickness comprised between 0 . 1 and 1000 nanometres , preferably between 1 and 20 nm . the amino groups may be deposited on the surface of the implantable device according to the methods widely known in the sector . the technique which provides for the introduction of the substrate having functional amino groups on the surface of the implantable device through plasma deposition of molecules carrying the amino groups is particularly advantageous . typical examples of molecules used for this purpose are allylamine , alkylamines such as hexylamine or heptylamine and , generally , organic molecules having amino functions which exhibit the required volatility characteristics in the plasma state . the plasma deposition of amine occurs in the following conditions : pressure comprised between 80 and 300 mtorrs , discharge power comprised between 5 and 200 w , deposition time between 1 ms and 300 s . plasma deposition may also occur in pulsed plasma conditions , with active and inactive plasma cycles comprised between 1 and 100 ms , to minimize the molecular fragmentation and maintain the highest density possible of the amino groups . the plasma deposition treatment of amines may be preceded by other plasma treatments , for example using air or oxygen plasma for cleaning the surface and increasing adhesion with the substrate . a further method for coating the implantable device with a substrate containing amino groups consists in adsorbing polyethyleneimine ( pei ) on the device surface , for example from a 0 . 2 % aqueous solution , for 2 hours , at ambient temperature . also the use of silanes , for example 3 - aminopropyltriethoxysilane ( aptes ), or analogous compounds , falls within the common methods of surface functionalization . it is also possible to functionalise the surface of the implantable device with carboxyl groups through plasma deposition of acrylic / methacrylic acid . furthermore , it is possible to functionalise the surface with natural molecules , possibly bioactive , which are irreversibly adsorbed on the surface and have amino / carboxylic groups suitable for the subsequent bond of hyaluronic acid and complexes thereof with vancomycin . typical examples falling within this category are collagen and other extracellular matrix protein molecules , such as laminin , fibronectin , vitronectin . according to this embodiment , the implanting device according to the invention comprises a first layer of adsorbed collagen , in a monomer or fibrillated form , to which hyaluronic acid is bonded , according to the described process , preferably through edc / nhs , or through reductive amination . this is followed by the formation of the hyaluronic acid / vancomycin complexes , through exposure to vancomycin and cross - linking or condensing agents solutions . the functionalization with collagen is preferably performed with a 0 . 3 % collagen solution in 10 mm acetic acid and an equal volume of phosphate buffer at 37 ° c . for 8 hours . the previously described method may also be performed on collagen in suspension , leading to the formation — in the aqueous medium — of a precipitate of complex of fibrillated collagen , hyaluronic acid and glycopeptide antibiotic ( such as vancomycin ), which can be separated , washed and partly dried to obtain a gel . this gel based on collagen and containing said glycopeptide antibiotic and hyaluronic acid can be used , as it is or in lyophilized forms and reconstructed when using , as filling material in the site of fixation of said implantable device , performing both the typical osteointegration action of collagen and hyaluronic acid as well as the antibacterial activity of the antibiotic also in the region surrounding the implant . a further object of the invention is a kit comprising an implanting device on the human or animal body , in which at least one part of the surface of said device is coated with a hyaluronic acid complex with a glycopeptide antibiotic , and a fibrillated collagen gel with said hyaluronic acid / glycopeptide antibiotic complex . this example shows that there is a surprising interaction between vancomycin and hyaluronic acid . a 0 . 1 % ( w / v ) solution of hyaluronic acid hw ( molecular weight 800 kda , lifecore ) in milliq water and a 0 . 5 % vancomycin solution in milliq water is prepared . the hyaluronic acid solution is gradually added to the latter solution and a gradual increase of the turbidity of the solution up to the formation of particles in suspension is observed ( sign of strong interaction between ha and vancomycin ). if two condensing agents , n - hydroxysuccinimide and subsequently ethyl - carbodiimide are added to the mixture , the solution turns instantly limpid . however , after 15 hours , the mixture becomes very turbid , with the presence of precipitates in suspension : probably the condensing agents are capable of bonding the amino groups of vancomycin to the carboxyl groups of the hyaluronic acid . such precipitates were collected , washed with milliq water and subsequently analysed under ir : fig1 shows the spectra relative to vancomycin ( dots ), hyaluronic acid ( dashes ) and the precipitate formed through the described method ( continuous ). in this spectrum there are signals of vancomycin and signals of hyaluronic acid , confirming interaction between the two molecules . this example shows the fundamental role of condensing agents in the interaction between vancomycin and hyaluronic acid . the previous experiment is repeated using hyaluronic acid and vancomycin solutions at very low concentrations ( up to 10 times lower ): in these cases , the addition of hyaluronic acid to a vancomycin solution does not cause an immediate turbidity of the mixture , which remains limpid . however , by adding the same amounts of condensing agents used in the previous experiment and leaving in incubation for about 15 hours , the solution turns turbid ( even though at a lower degree with respect to the large precipitates formed in the previous experiment ), proving that the ha - vancomycin interaction is somehow “ stimulated ” by the presence of condensing agents . solutions with high concentration of vancomycin in water ( 1 %) and ha in water ( 0 . 5 %) were prepared with the aim of observing possible differences between the ha - vancomycin interaction that occurs in presence or in absence of condensing agents . such solutions were mixed and the precipitate immediately formed was collected , washed and analysed under ir . the spectrum relative to this precipitate was then compared with that relative to the precipitate that is formed in presence of condensing agents . fig2 shows — through a dotted and solid line — the spectra of ha and vancomycin respectively , while the long dash line shows the spectrum of the ha - vancomycin precipitate in presence of condensing agents and the short dash line shows the spectrum of the precipitate in absence of condensing agents . there are two important signals present in the spectrum in long dash line and not in the short dash line : the first is at 1550 cm - 1 , which could be the signal of the secondary amide ( bending nh2 and stretching cn ); the second is at 840 cm - 1 and it could be the signal of aliphatic amines and the bending ocn . these two signals , solely present in the spectrum of the precipitate formed in presence of condensing agents ( but not actually belonging to the condensing agents ), could indicate that bonds different from those deriving from simple electrostatic interaction , such as covalent bonds , specific interactions or other interactions formed in such precipitate . potential existence of a strong interaction between hyaluronic acid and vancomycin has paved the way towards new surface modification experiments . such experiments consist in covalently bonding hyaluronic acid to a suitably functionalized surface , then incubating the abovementioned surface in a solution of vancomycin in presence of condensing agents , so as to directly provide the same reaction observed in the solution on the surface . this example shows that the process observed in solution also occurs directly on the surface of a material . air plasma treatment for 20 seconds incubation with polyethyleneimine solution ( pei ) 0 . 5 % in water for 2 hours washing with milliq water ( 3 times ) incubation of the polystyrene surfaces o . n . with hyaluronic acid solution 800 kda 0 . 2 % ( lifecore ) in milliq water , in presence of 5 mg / cc nhs and 7 . 5 mg / cc edc . washing with milliq water ( 2 times ) incubation with 0 . 7 % vancomycin solution in water overnight , in presence of 5 mg / cc nhs and 7 . 5 mg / cc edc . washing with milliq water ( 3 times ) at the end of the treatment on the polystyrene surfaces thus prepared a very homogeneous opaque thin layer , derived from the occurred interaction between hyaluronic acid bonded on the surface in the first reaction step and the vancomycin added in the second reaction step is observed . polystyrene surfaces treated in the same manner but in absence of nhs and edc during the second incubation in vancomycin solution , are perfectly transparent hence confirming the importance of the condensing agents . process for coating an implant screw made of titanium with hyaluronic acid and vancomycin some implant screws made of titanium , with a length of 13 mm and width of 4 mm , are treated as follows : sample 2 : surface functionalization using pei , and ha bonding like in example 3 ( ti - ha sample ). sample 3 : a sample treated like in point 2 was subsequently subjected to incubation with a 0 . 7 % vancomycin solution in water overnight , in presence of 5 mg / cc nhs and 7 . 5 mg / cc edc and subsequent washing with milliq water ( ti - ha - vxl sample ) the samples thus obtained were subsequently subjected to xps ( x - ray photoelectron spectroscopy ) analysis to evaluate the chemical composition of the surface . a sample of vancomycin , obtained by leaving a solution of vancomycin in milliq water to evaporate on a plastic substrate was analysed therealong as reference . the following results were obtained , expressed in percentage of atoms and reminding that the xps analysis does not measure the presence of hydrogen atoms : the vancomycin molecule is characterised , for analytical purposes regarding this evaluation , by the presence of the cl hetero - element ( two atoms in a compound also comprising o , c and n with molecular weight of about 1450 da ). the presence of cl , at an atomic percentage lower than 2 %, is actually shown by the xps analysis , as indicated in the table , in the line indicating the analysis of vancomycin . the surfaces of the ti screw and of the ti - ha screw are characterised by composition values in line with the expectations , as observable from the literature of the sector . the composition of the surface of the ti - ha - vxl sample is different from that of ti - ha due to the presence of cl , hence the introduction of the vancomycin molecule on the surface . example of the importance of the molecular weight of hyaluronic acid on the release of vancomycin from surfaces modified through the present process modified polystyrene surfaces with different molecular weights of ha and then with the vancomycin solution in presence of nhs and edc were prepared to observe the specificity of the ha - vancomycin reaction . ha lw ( 10 kda ), ha mw ( about 70 kda ), ha hw ( 880 kda ) and ha hhw ( about 2000 kda ) were used . thus , the surfaces were first functionalised with polyethyleneimine ( 0 . 5 % solution in water for 2 hours ); then incubation was conducted overnight with the ha solutions with different molecular weight in presence of nhs and edc . washing was subsequently carried out in water and then the surfaces were incubated overnight with a 0 . 8 % vancomycin solution in water in presence of 5 mg / ml nhs and 7 . 5 mg / ml of edc . the opacity of the surface was observed solely with the ha hw weight , even though for ha mw and ha hhw the wells did not appear perfectly transparent : thus , there is a certain specificity , even though only dimensional , in the interaction between vancomycin and ha hw . at the end of the washing , the surfaces were incubated in pbs to conduct the analysis of vancomycin release over time through hplc . the chart in fig3 shows the amount of vancomycin released by the different surfaces over time ( one month ): it can be observed that the surface modified with ha hw releases a greater amount of antibiotic with respect to those modified with the other molecular weights . influence of the functionalization process on the amount of vancomycin released by surfaces modified through the present process the treatment of two 6 - wells of polystyrene with ha + vxl ( vxl = vancomycin and condensing agents edc - nhs ), but functionalizing the surfaces with pei ( polyethyleneimine ) or with fibrillated collagen was planned to verify whether functionalization with fibrillated collagen causes some changes in the rate of releasing vancomycin from the polystyrene surfaces . the 6 - wells were plasma treated like in the previous example , then the wells were incubated with a solution of pei 0 . 5 % in water for 2 hours or with a 0 . 3 % collagen solution in 10 mm acetic acid and an equal volume of pbs a 37 ° c . for 8 hours . before the step of functionalizing , the surfaces were treated with a 0 . 2 % ha hw solution in presence of nhs and edc overnight , then washed with milliq water and incubated with a 0 . 75 % vancomycin solution in water in presence of nhs and edc overnight . at the end of such incubation , the surfaces were washed with milliq water and dried . releasing step was conducted in pbs at 37 ° c ., with the measurement of the amount released at 4 hours , 24 hours , 4 days , 12 days and 21 days through hplc . all the times revealed that the surfaces modified with collagen release a greater amount of antibiotic with respect to those functionalised with pei . the chart in fig4 shows the cumulative curve of the release of vancomycin from the differently functionalised surfaces : it can be observed that , at each time point , the surfaces functionalized with fibrillated collagen release a greater amount of vancomycin . this example indicates that , for surprising and not entirely clear reasons , the surface functionalization step , in particular the molecular species used for the surface functionalization , influences the total amount of vancomycin “ captured ” from the surface coated with hyaluronic acid and / or the amount of vancomycin that the surface coated with hyaluronic acid is capable of releasing . going beyond the importance of this observation from an applicative point of view , the result confirms that the observed phenomenon is not a general effect of the action of edc - nhs on the vancomycin in solution , but it is bonded in a surprising and unexpected manner to the molecular structure of the surface . in order to evaluate the response of the mesenchymal cells to the coating process and thus verifying whether the latter can also have effects on osteogenesis , mesenchymal cells were cultured on the following surfaces , provided on plates with micro - wells for cellular cultures : plastic for cellular cultures ( control ) plastic for cultures functionalised with pei and subsequent covalent bond of hyaluronic acid 800 kda ( ha ) plastic for cultures functionalised with pei and subsequent covalent bond of hyaluronic acid 800 kda , followed by the formation of ha - vancomycin complexes as described in the previous example ( ha − vxl ) mesenchymal cells from human bone marrow were acquired from lonza milano srl in undifferentiated form . as known , according to external stimuli , these cells can differentiate along some different paths , including the osteogenic one . the cells were cultured in an osteogenic medium and the expression of some genes responsible for the formation of bone tissue thereof was evaluated through real time polymerase chain reaction ( rt - pcr ) analysis . the data are reported in the following table , where “=” means expression equivalent to that of the control , “+” expression up to 5 times greater than that of the control , “++” expression greater than 5 times that of the control . these data confirm that coating with ha stimulates the expression of genes linked to the formation of bone tissue , confirming the in vivo data cited in literature regarding the effect of the covalent bond of surface layers of ha on osteointegration ( morra et al . covalently - linked hyaluronan promotes bone formation around ti implants in a rabbit model , published on the journal of orthopedic research , 27 : 657 - 663 , 2009 ). in particular , both the runx2 transcription factor , which controls the cellular differentiation , and in particular the bmp - 2 protein and the bsp ( bone sialoprotein ) are markedly over - expressed on ha and ha − vxl with respect to the control , and they indicate an extremely significant osteogenic process . the presence of the complexes with vancomycin does not substantially alter the advantages of ha ( on the contrary , another very important gene , alkaline phosphatase , appears more expressed on ha − vxl with respect to ha ), confirming that also this type of surface is pro - osteogenic . this is a very important property , which combined with the peculiar release of the antibiotic , is at the base of the generation and design of multifunctional devices . verification of the antibacterial efficiency of implant screws obtained according to the present process inhibition areola tests were conducted in staphylococcus epidermidis cultures with the aim of proving the antibacterial action of the present invention . implants coated with ha and with ha − vxl are provided through the methods described previously . these implants , alongside the negative control ones ( untreated implants ), were then incubated in a semi - solid agar medium together with the bacterial mixture in a petri dish at 37 ° c . the bacteria should proliferate and , in the case of a surface with antibacterial properties ( with release of antibiotic ), an inhibition areola , i . e . an area without bacteria surrounding the implant , should form around the implant . the results of this experiment confirmed that the developed treatment has antibacterial activities : actually , around the ha + vxl implants the inhibition areola , which is not formed around the control implants , is observed . fig5 represents a picture explaining the experiment , with the control implants at the top ( only titanium on the left , ti coated with ha on the right ) and the treated ones at the bottom ( ha − vxl , two replicas ), around which the inhibition areola is clearly observable . the implants thus treated were subsequently collected and once again submerged into an agar containing bacteria to verify whether they would maintain their antibacterial activity : actually , the inhibition areola forms around the treated implants also in this second incubation , even though having a diameter slightly smaller with respect to the one formed the first time . the same happened also in the case of a third incubation . thus the surfaces of the ha − vxl implants reveal the greater osteogenic characteristics of hyaluronic acid , as shown by the example 7 , with which the antibacterial properties revealed by the results exemplified by the photograph indicated in fig5 are combined . thus , this example confirms the multifunctional nature of the surface obtained according to the present process , and the applicative advantage thereof both with respect to the conventional device ( screw made of titanium ) and with respected to the device coated with ha described in the art . embodiment of a fracture fixation screw made of titanium , with roughened surface and coating with hyaluronic acid - vancomycin a screw made of titanium degree 5 for fracture fixation is used for the demonstration of the preparation of an implant device with multifunctional surface , having the following properties : rough surface and ensuing increase of surface area bioactive surface through hyaluronic acid bond upon functionalization through adsorption of fibrillated collagen antibacterial surface through the release of the vancomycin present in complexes with hyaluronic acid bonded to the surface . the apical portion ( head ) of the screw is produced through masking and the screw is subjected to a sand - blasting process for 40 seconds in a norblast sandblasting machine , using titanium oxides as sanding agent . the screw is then subjected to a treatment process with acids , according to protocols commonly used by this company to treat dental implants and then subjected to the process in question like in example 7 and 8 . the roughened surface of the screw has a surface area , and thus a contact surface , more than 70 % greater than that of a conventional screw . it is obvious that only some particular embodiments of the present invention have been described and they can be subjected — by a man skilled in the art — to any modifications required for adaptation thereof to particular applications without departing from the scope of protection of the present invention .